In the BioHarmony Drug Report Database

"Preview" Icon

Salmeterol

Serevent, BroPair Spiromax, Seffalair Spiromax (salmeterol) is a small molecule pharmaceutical. Salmeterol was first approved as Serevent on 1994-02-04. It is used to treat asthma and bronchial spasm in the USA. It has been approved in Europe to treat asthma. The pharmaceutical is active against beta-2 adrenergic receptor.

 

Trade Name

 

BroPair Spiromax, Seffalair Spiromax
 

Common Name

 

salmeterol
 

ChEMBL ID

 

CHEMBL1263
 

Indication

 

asthma, bronchial spasm
 

Drug Class

 

Bronchodilators (phenethylamine derivatives); anti-inflammatory agents (salicylic acid derivatives)

Image (chem structure or protein)

Salmeterol structure rendering